Mobile medical is experiencing a smooth post-war, and startups need to learn from the experience of successful companies and return to the essence of business. The medical industry is everywhere in the world, but without a pair of eye-catching eyes, it is a minute to miss the ten-fold share that is sent to the door. Three years ago, the author interviewed Mr. Chen Haibin, the chairman of Dean Diagnostics, to write an interview outline, from the prospectus to the annual report, to the latest announcement, and even some of the latest research reports, and did a lot of homework. In the Q&A session, Chen Haibin also had a question and answer, and the author visited the Shanghai Center of Dean Diagnostics. The leaders of the Shanghai Center also shared their latest business data. Even let me visit the Shanghai Center and talk to the staff. Even so, after the interview, my colleague asked, what about the company? I replied, very good technology service company, but the stock has already risen. In the days that followed, I saw that it had risen all the way, went straight into the sky, and finally became a ten-fold stock. Looking back at Dean's diagnosis at that time, it was a small spray. Three years later, Chen Haibin, who has become an instructor of Qiqi’s entrepreneurship, finally understands where it was wrong. First, the mistaken diagnosis of Dean diagnosis as a conventional technology company, its market potential is limited to the B-end, they did not expect that they can also enter the C-end, its market ceiling is the population ceiling; second, they did not see them. The potential of big data, the concept of big data at that time was still a very secluded concept; the third, and the most deadly mistake, neglected the driving force of medical reform on the market, and did not timely learn from the precedents of overseas medical reform for the promotion of the industry, also known as the policy cusp . This may be an interesting place for the big health industry. With the absolute population as the market ceiling, we must always keep an eye on the policy trend, but ultimately it is the inevitable law that is universally applicable, especially overseas experience. A good business project is a good business story. The story will eventually grow into a great company in reality. It requires the story itself to be logically self-consistent and justified. The people who listen to the story must also look at the torch, keep an eye on the market hotspots, and have to take into account the big pattern at home and abroad. Why can the big health industry produce ten times as many shares? What is the business logic of Dean Diagnostics? Please see how Chen Haibin, the entrepreneurial tutor of Qiqi, said that he has a methodology for investing and doing industry. Dean Diagnostics Qi Wei: Judging whether a health project has value, for example, what is the value of Dean Diagnostics? Chen Haibin: We see that there is a development theory in the enterprise, which is the benchmark. The independent laboratory in the United States has a history of six or seventy years. From the stage of the early staking, to the stage of the special project in the medium term, to the recent Integration of diagnosis and treatment, with clinical new drugs to do accompanying diagnostic projects, each step is a take-off. For today's China Independent Laboratory, although the development time is only 10 years, these three stages are almost at the same time, which is China's late-comer advantage. Through the strategic thinking of the leading US companies, combined with China's actual business environment, we strive to seize these opportunities at the same time. The cooperation between Dean Diagnostics and Tiger Pharmaceuticals is to use the potential and leverage to develop the trending and directional new projects of independent laboratories as soon as possible. Collagen is the most abundant protein in mammals, accounting for 25% to 30% of the total protein. It is widely present in all tissues from the body surface of lower vertebrates to mammalian bodies. Collagen monomers are long cylindrical proteins with a length of about 280 nm and a diameter of 1.4–1.5 nm. It consists of 3 polypeptide chains that are supercoiled around each other. Collagen,Collagen Peptides,Collagen costco,Collagen Peptide Products YT(Xi'an) Biochem Co., Ltd. , https://www.ytwholefood.com